Dualmarker: a flexible toolset for exploratory analysis of combinatorial dual biomarkers for clinical efficacy.

BMC Bioinformatics · 2021 · PMC7972341 · PMID 33731020

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Meanwhile, the ARID1A-mut group showed a trend of longer OS than the ARID1A-wildtype group in both CXCL13-high and CXCL13-low subgroups (Fig. 3 g, lower 2 panels).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.